Supplementary Figure S8 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S9 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results Dahkki Nigel Bundred (15046233)

Fáttát:

Figure 3 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results Dahkki Nigel Bundred (15046233)

Fáttát:

Supplementary Table S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Table 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results Dahkki Nigel Bundred (15046233)

Fáttát:

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Table S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S6 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Figure S2 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Focused operations to improve the patient flow in full-service healthcare organisations Dahkki Philip Åhlin (15257749)

Fáttát: “…Medicine…”

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Canc... Dahkki Andrew A. Davis (15030032)

Fáttát:

Factors and outcomes associated with acute kidney injury in brain tumor resection patients: insights from a large US database (2010–2019) Dahkki Binbin Tian (21738944)

Fáttát: “…Medicine…”

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát:

Additional file 2 of Shared decision-making and behaviour change collide: an analysis of consultations discussing clinical trial recruitment Dahkki Abigail Stephen (22678312)

Fáttát: “…Medicine…”

Supplementary Figure S7 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Dahkki Rohit Thummalapalli (17314483)

Fáttát: